Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Rabies Vaccine Market, by Prophylaxis Type
1.4.2 Global Rabies Vaccine Market, by End User
1.4.3 Global Rabies Vaccine Market, by Application
1.4.4 Global Rabies Vaccine Market, by Product Type
1.4.5 Global Rabies Vaccine Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Rabies Vaccine Market by Prophylaxis Type
4.1 Global Post-exposure Prophylaxis Market by Region
4.2 Global Pre-exposure prophylaxis Market by Region
Chapter 5. Global Rabies Vaccine Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Veterinary Clinics Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Rabies Vaccine Market by Application
6.1 Global Human Market by Region
6.2 Global Animal Market by Region
Chapter 7. Global Rabies Vaccine Market by Product Type
7.1 Global Chick Embryo Cells Rabies Vaccine Market by Region
7.2 Global Human Diploid Cell Vaccine Market by Region
7.3 Global Vero Cell Rabies Vaccine Market by Region
7.4 Global Others Market by Region
Chapter 8. Global Rabies Vaccine Market by Region
8.1 North America Rabies Vaccine Market
8.1.1 North America Rabies Vaccine Market by Prophylaxis Type
8.1.1.1 North America Post-exposure Prophylaxis Market by Region
8.1.1.2 North America Pre-exposure prophylaxis Market by Region
8.1.2 North America Rabies Vaccine Market by End User
8.1.2.1 North America Hospitals Market by Country
8.1.2.2 North America Veterinary Clinics Market by Country
8.1.2.3 North America Others Market by Country
8.1.3 North America Rabies Vaccine Market by Application
8.1.3.1 North America Human Market by Country
8.1.3.2 North America Animal Market by Country
8.1.4 North America Rabies Vaccine Market by Product Type
8.1.4.1 North America Chick Embryo Cells Rabies Vaccine Market by Country
8.1.4.2 North America Human Diploid Cell Vaccine Market by Country
8.1.4.3 North America Vero Cell Rabies Vaccine Market by Country
8.1.4.4 North America Others Market by Country
8.1.5 North America Rabies Vaccine Market by Country
8.1.5.1 US Rabies Vaccine Market
8.1.5.1.1 US Rabies Vaccine Market by Prophylaxis Type
8.1.5.1.2 US Rabies Vaccine Market by End User
8.1.5.1.3 US Rabies Vaccine Market by Application
8.1.5.1.4 US Rabies Vaccine Market by Product Type
8.1.5.2 Canada Rabies Vaccine Market
8.1.5.2.1 Canada Rabies Vaccine Market by Prophylaxis Type
8.1.5.2.2 Canada Rabies Vaccine Market by End User
8.1.5.2.3 Canada Rabies Vaccine Market by Application
8.1.5.2.4 Canada Rabies Vaccine Market by Product Type
8.1.5.3 Mexico Rabies Vaccine Market
8.1.5.3.1 Mexico Rabies Vaccine Market by Prophylaxis Type
8.1.5.3.2 Mexico Rabies Vaccine Market by End User
8.1.5.3.3 Mexico Rabies Vaccine Market by Application
8.1.5.3.4 Mexico Rabies Vaccine Market by Product Type
8.1.5.4 Rest of North America Rabies Vaccine Market
8.1.5.4.1 Rest of North America Rabies Vaccine Market by Prophylaxis Type
8.1.5.4.2 Rest of North America Rabies Vaccine Market by End User
8.1.5.4.3 Rest of North America Rabies Vaccine Market by Application
8.1.5.4.4 Rest of North America Rabies Vaccine Market by Product Type
8.2 Europe Rabies Vaccine Market
8.2.1 Europe Rabies Vaccine Market by Prophylaxis Type
8.2.1.1 Europe Post-exposure Prophylaxis Market by Country
8.2.1.2 Europe Pre-exposure prophylaxis Market by Country
8.2.2 Europe Rabies Vaccine Market by End User
8.2.2.1 Europe Hospitals Market by Country
8.2.2.2 Europe Veterinary Clinics Market by Country
8.2.2.3 Europe Others Market by Country
8.2.3 Europe Rabies Vaccine Market by Application
8.2.3.1 Europe Human Market by Country
8.2.3.2 Europe Animal Market by Country
8.2.4 Europe Rabies Vaccine Market by Product Type
8.2.4.1 Europe Chick Embryo Cells Rabies Vaccine Market by Country
8.2.4.2 Europe Human Diploid Cell Vaccine Market by Country
8.2.4.3 Europe Vero Cell Rabies Vaccine Market by Country
8.2.4.4 Europe Others Market by Country
8.2.5 Europe Rabies Vaccine Market by Country
8.2.5.1 Germany Rabies Vaccine Market
8.2.5.1.1 Germany Rabies Vaccine Market by Prophylaxis Type
8.2.5.1.2 Germany Rabies Vaccine Market by End User
8.2.5.1.3 Germany Rabies Vaccine Market by Application
8.2.5.1.4 Germany Rabies Vaccine Market by Product Type
8.2.5.2 UK Rabies Vaccine Market
8.2.5.2.1 UK Rabies Vaccine Market by Prophylaxis Type
8.2.5.2.2 UK Rabies Vaccine Market by End User
8.2.5.2.3 UK Rabies Vaccine Market by Application
8.2.5.2.4 UK Rabies Vaccine Market by Product Type
8.2.5.3 France Rabies Vaccine Market
8.2.5.3.1 France Rabies Vaccine Market by Prophylaxis Type
8.2.5.3.2 France Rabies Vaccine Market by End User
8.2.5.3.3 France Rabies Vaccine Market by Application
8.2.5.3.4 France Rabies Vaccine Market by Product Type
8.2.5.4 Russia Rabies Vaccine Market
8.2.5.4.1 Russia Rabies Vaccine Market by Prophylaxis Type
8.2.5.4.2 Russia Rabies Vaccine Market by End User
8.2.5.4.3 Russia Rabies Vaccine Market by Application
8.2.5.4.4 Russia Rabies Vaccine Market by Product Type
8.2.5.5 Spain Rabies Vaccine Market
8.2.5.5.1 Spain Rabies Vaccine Market by Prophylaxis Type
8.2.5.5.2 Spain Rabies Vaccine Market by End User
8.2.5.5.3 Spain Rabies Vaccine Market by Application
8.2.5.5.4 Spain Rabies Vaccine Market by Product Type
8.2.5.6 Italy Rabies Vaccine Market
8.2.5.6.1 Italy Rabies Vaccine Market by Prophylaxis Type
8.2.5.6.2 Italy Rabies Vaccine Market by End User
8.2.5.6.3 Italy Rabies Vaccine Market by Application
8.2.5.6.4 Italy Rabies Vaccine Market by Product Type
8.2.5.7 Rest of Europe Rabies Vaccine Market
8.2.5.7.1 Rest of Europe Rabies Vaccine Market by Prophylaxis Type
8.2.5.7.2 Rest of Europe Rabies Vaccine Market by End User
8.2.5.7.3 Rest of Europe Rabies Vaccine Market by Application
8.2.5.7.4 Rest of Europe Rabies Vaccine Market by Product Type
8.3 Asia Pacific Rabies Vaccine Market
8.3.1 Asia Pacific Rabies Vaccine Market by Prophylaxis Type
8.3.1.1 Asia Pacific Post-exposure Prophylaxis Market by Country
8.3.1.2 Asia Pacific Pre-exposure prophylaxis Market by Country
8.3.2 Asia Pacific Rabies Vaccine Market by End User
8.3.2.1 Asia Pacific Hospitals Market by Country
8.3.2.2 Asia Pacific Veterinary Clinics Market by Country
8.3.2.3 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Rabies Vaccine Market by Application
8.3.3.1 Asia Pacific Human Market by Country
8.3.3.2 Asia Pacific Animal Market by Country
8.3.4 Asia Pacific Rabies Vaccine Market by Product Type
8.3.4.1 Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country
8.3.4.2 Asia Pacific Human Diploid Cell Vaccine Market by Country
8.3.4.3 Asia Pacific Vero Cell Rabies Vaccine Market by Country
8.3.4.4 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Rabies Vaccine Market by Country
8.3.5.1 China Rabies Vaccine Market
8.3.5.1.1 China Rabies Vaccine Market by Prophylaxis Type
8.3.5.1.2 China Rabies Vaccine Market by End User
8.3.5.1.3 China Rabies Vaccine Market by Application
8.3.5.1.4 China Rabies Vaccine Market by Product Type
8.3.5.2 Japan Rabies Vaccine Market
8.3.5.2.1 Japan Rabies Vaccine Market by Prophylaxis Type
8.3.5.2.2 Japan Rabies Vaccine Market by End User
8.3.5.2.3 Japan Rabies Vaccine Market by Application
8.3.5.2.4 Japan Rabies Vaccine Market by Product Type
8.3.5.3 India Rabies Vaccine Market
8.3.5.3.1 India Rabies Vaccine Market by Prophylaxis Type
8.3.5.3.2 India Rabies Vaccine Market by End User
8.3.5.3.3 India Rabies Vaccine Market by Application
8.3.5.3.4 India Rabies Vaccine Market by Product Type
8.3.5.4 South Korea Rabies Vaccine Market
8.3.5.4.1 South Korea Rabies Vaccine Market by Prophylaxis Type
8.3.5.4.2 South Korea Rabies Vaccine Market by End User
8.3.5.4.3 South Korea Rabies Vaccine Market by Application
8.3.5.4.4 South Korea Rabies Vaccine Market by Product Type
8.3.5.5 Singapore Rabies Vaccine Market
8.3.5.5.1 Singapore Rabies Vaccine Market by Prophylaxis Type
8.3.5.5.2 Singapore Rabies Vaccine Market by End User
8.3.5.5.3 Singapore Rabies Vaccine Market by Application
8.3.5.5.4 Singapore Rabies Vaccine Market by Product Type
8.3.5.6 Malaysia Rabies Vaccine Market
8.3.5.6.1 Malaysia Rabies Vaccine Market by Prophylaxis Type
8.3.5.6.2 Malaysia Rabies Vaccine Market by End User
8.3.5.6.3 Malaysia Rabies Vaccine Market by Application
8.3.5.6.4 Malaysia Rabies Vaccine Market by Product Type
8.3.5.7 Rest of Asia Pacific Rabies Vaccine Market
8.3.5.7.1 Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type
8.3.5.7.2 Rest of Asia Pacific Rabies Vaccine Market by End User
8.3.5.7.3 Rest of Asia Pacific Rabies Vaccine Market by Application
8.3.5.7.4 Rest of Asia Pacific Rabies Vaccine Market by Product Type
8.4 LAMEA Rabies Vaccine Market
8.4.1 LAMEA Rabies Vaccine Market by Prophylaxis Type
8.4.1.1 LAMEA Post-exposure Prophylaxis Market by Country
8.4.1.2 LAMEA Pre-exposure prophylaxis Market by Country
8.4.2 LAMEA Rabies Vaccine Market by End User
8.4.2.1 LAMEA Hospitals Market by Country
8.4.2.2 LAMEA Veterinary Clinics Market by Country
8.4.2.3 LAMEA Others Market by Country
8.4.3 LAMEA Rabies Vaccine Market by Application
8.4.3.1 LAMEA Human Market by Country
8.4.3.2 LAMEA Animal Market by Country
8.4.4 LAMEA Rabies Vaccine Market by Product Type
8.4.4.1 LAMEA Chick Embryo Cells Rabies Vaccine Market by Country
8.4.4.2 LAMEA Human Diploid Cell Vaccine Market by Country
8.4.4.3 LAMEA Vero Cell Rabies Vaccine Market by Country
8.4.4.4 LAMEA Others Market by Country
8.4.5 LAMEA Rabies Vaccine Market by Country
8.4.5.1 Brazil Rabies Vaccine Market
8.4.5.1.1 Brazil Rabies Vaccine Market by Prophylaxis Type
8.4.5.1.2 Brazil Rabies Vaccine Market by End User
8.4.5.1.3 Brazil Rabies Vaccine Market by Application
8.4.5.1.4 Brazil Rabies Vaccine Market by Product Type
8.4.5.2 Argentina Rabies Vaccine Market
8.4.5.2.1 Argentina Rabies Vaccine Market by Prophylaxis Type
8.4.5.2.2 Argentina Rabies Vaccine Market by End User
8.4.5.2.3 Argentina Rabies Vaccine Market by Application
8.4.5.2.4 Argentina Rabies Vaccine Market by Product Type
8.4.5.3 UAE Rabies Vaccine Market
8.4.5.3.1 UAE Rabies Vaccine Market by Prophylaxis Type
8.4.5.3.2 UAE Rabies Vaccine Market by End User
8.4.5.3.3 UAE Rabies Vaccine Market by Application
8.4.5.3.4 UAE Rabies Vaccine Market by Product Type
8.4.5.4 Saudi Arabia Rabies Vaccine Market
8.4.5.4.1 Saudi Arabia Rabies Vaccine Market by Prophylaxis Type
8.4.5.4.2 Saudi Arabia Rabies Vaccine Market by End User
8.4.5.4.3 Saudi Arabia Rabies Vaccine Market by Application
8.4.5.4.4 Saudi Arabia Rabies Vaccine Market by Product Type
8.4.5.5 South Africa Rabies Vaccine Market
8.4.5.5.1 South Africa Rabies Vaccine Market by Prophylaxis Type
8.4.5.5.2 South Africa Rabies Vaccine Market by End User
8.4.5.5.3 South Africa Rabies Vaccine Market by Application
8.4.5.5.4 South Africa Rabies Vaccine Market by Product Type
8.4.5.6 Nigeria Rabies Vaccine Market
8.4.5.6.1 Nigeria Rabies Vaccine Market by Prophylaxis Type
8.4.5.6.2 Nigeria Rabies Vaccine Market by End User
8.4.5.6.3 Nigeria Rabies Vaccine Market by Application
8.4.5.6.4 Nigeria Rabies Vaccine Market by Product Type
8.4.5.7 Rest of LAMEA Rabies Vaccine Market
8.4.5.7.1 Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type
8.4.5.7.2 Rest of LAMEA Rabies Vaccine Market by End User
8.4.5.7.3 Rest of LAMEA Rabies Vaccine Market by Application
8.4.5.7.4 Rest of LAMEA Rabies Vaccine Market by Product Type
Chapter 9. Company Profiles
9.1 Cadila Pharmaceuticals Limited
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Product Launches and Product Expansions:
9.2 Bharat Biotech Ltd.
9.2.1 Company Overview
9.3 Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
9.3.1 Company Overview
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Elanco Animal Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Zoetis, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Novartis AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Sanofi S.A.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Virbac
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 SWOT Analysis
Chapter 10. Winning imperative of Rabies Vaccine Market
Unique Offerings 